Quality Investor

Alkami Technology, Inc.

Rank #218Hypergrowth

ALKT · Nasdaq · Technology

Alkami Technology, Inc. (ALKT) — Rank #218 by gross profitability (GP/assets 0.31) · ROE -13.1% · Piotroski F-Score N/A.

As-of 2026-09-15 · CIK 0001529274 · all metrics point-in-time as of the filing date.

About

Alkami Technology, Inc. provides a cloud-based digital sales and service platform for financial institutions in the United States.

Show more

The company offers the Alkami digital sales & service platform, which includes the Alkami digital banking platform, onboarding & account opening, and data & marketing modules. Its solutions enable financial institutions to onboard and engage new users, accelerate revenues, and enhance operational efficiency, with the support of proprietary, cloud-based, and multi-tenant architecture. It serves community, regional, super-regional credit unions, and banks.

The company was founded in 2009 and is based in Plano, Texas.

Industry
Software - Application
Sector
Technology
State
DE
Filer Category
Large accelerated filer
Fiscal Year End
December 31
Website
alkami.com

Price History

ALKT-31.5% · -7.3% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/S is the primary valuation lens — earnings are reinvested, not available for P/E.

Market Cap

$2.14B

P/E (annual)

P/S (annual)

4.8

P/B

5.9

P/OCF (annual)

50.0

Shareholder Yield

-2060.2%

Employees

1,225

Industry

Software - Application

Exchange

Nasdaq

Signal Flags

2 green2 yellow
Revenue growth acceleratingGrowth rate increasing year over year
Deferred revenue growingRevenue and deferred revenue both growing — retention signal
Dilution above 2%Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation
Disclosure regressionA previously-disclosed line item is no longer reported — worth checking the filing for why

Quality Profile

Profitability

1/1 pass
GP / assets
0.31
Return on equity
-13.1%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
1.29
Current ratio
2.13×
Net cash
$45.51M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
17.2%

Growth

1/2 pass
Revenue growth
295.6%
Piotroski F-Score
N/A
Share dilution
2060.2%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

2 of 5 thresholds not computable from filed data.

What Growth Is Priced In

Implied revenue growth (10Y)

20.3%

fairly valued

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Dilution drag: 2060.2% — per-share value needs a total required return of 2080.5% once share-count change is priced in.

vs. own 6-year median revenue growth: 35.7%

within its own history

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

15.3%

r = 10% (base)

20.3%

r = 12%

24.7%

Net debt / market cap: -2.2%

Base FCF: $41.4M3Y mean FCF: -$30.1M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / S

Price / revenue per share

6.9xExpensive
0.7xmed 3.8x6.9x

P / GP

Price / gross profit per share

13.0xExpensive
1.3xmed 7.1x13.0x

Revenue growth and the path to profitability (margin trend) are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.31

Primary signal (Novy-Marx).

38th pctl of 38 SIC 7372 peers

Return on equity

-13.1%

Gross margin

57.8%

24th pctl of 38 SIC 7372 peers

Revenue growth (YoY)

295.6%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2019202020212022
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

29.5%

Revenue CAGR (5Y)

31.7%

Earnings CAGR (3Y)

FCF CAGR (3Y)

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

1.29

9th pctl of 33 SIC 7372 peers (best = lowest)

Current ratio

2.13×

57th pctl of 38 SIC 7372 peers

Quick ratio

1.23×

Net cash

$45.51M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$41.36M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

1.87

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

17.2%

Stock-based comp intensity.

Piotroski F-Score

F-Score

N/A

Only 8/9 components determinable.

Lifecycle Phase History

20192022
Hypergrowth